{"organizations": ["Host", "American College of Rheumatology", "Unique Names for Biological Medicines", "World Patent Marketing's Hand Free Pocket Cop Invention", "Chaos Cantel Medical Corp", "Centers for Medicare and Medicaid Services", "Brain Aneurysm Awareness Month", "Forest Laboratories, Inc", "CANTEL MEDICAL CORP.", "Bedford Funding", "Wyle Business Development Staff", "Biologics Prescribers ... North American Society for Pediatric Gastroenterology", "Migraine Research Foundation", "Varian Medical Systems", "MDD", "Prostate Cancer Awareness Month ... Inc.", "Synapse Biomedical Inc ... Food and Drug Administration", "Creighton University of Omaha", "Rodman & Renshaw 17th Annual Global Investment Conference", "Cerner Corporation"], "uuid": "717ad05fad526d06936a8226218733ae0a495100", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Branded-Acute-Coronary-Syndrome-Therapies-to-Grab-Market-Share-from-Generic-Drugs-Globally-47911-1/", "country": "US", "title": "Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally", "spam_score": 0.0, "site_type": "news", "published": "2015-09-02T12:45:00.000+03:00", "replies_count": 0, "uuid": "717ad05fad526d06936a8226218733ae0a495100"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Branded-Acute-Coronary-Syndrome-Therapies-to-Grab-Market-Share-from-Generic-Drugs-Globally-47911-1/", "ord_in_thread": 0, "title": "Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally", "locations": ["United States", "Fla.", "Calif.", "America", "New York", "NY", "Houston", "Massachusetts", "Berlin", "SARASOTA", "Utah", "SEGUNDO"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Wyle", "Andrew Krakauer", "Parazynski", "Christine Buckley", "Krakauer", "Seth R. Segel", "David Stirling"], "text": " 9/2/2015)... 2, 2015 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a ... a broad range of cancer types and other conditions, today ... is scheduled to present at the 17 th Annual ... 2015 in New York, NY . In ... will be presenting at the CNAPS (Circulating Nucleic Acids in   2, 2015 On Tuesday, September ... of physicians who prescribe biologics – Alliance ... Endocrinologists, American College of Rheumatology, Biologics Prescribers ... North American Society for Pediatric Gastroenterology, Hepatology ... Centers for Medicare and Medicaid Services (CMS)   SARASOTA, Fla. , Sept. 2, 2015 ... announced a new capital infusion of $17 million by ... of Cerner Corporation, and Bedford Funding. Series D funding ... Voalte has raised to nearly $60 million in three ... to sustain a triple-digit growth trajectory for Voalte. The ... [ 0 ] VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 [ 0 ] Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines [ 0 ] Voalte Raises $17 Million in Series D Financing ... Synapse Biomedical Inc ... Food and Drug Administration (FDA) designation of the ... Use Device (HUD) for amyotrophic lateral sclerosis ( ALS ... chronic hypoventilation and has now submitted for Humanitarian Device ... ... Varian Medical Systems (NYSE: VAR ) announced ... fiscal year 2010 following the close of regular trading on ... by a teleconference available to all interested parties at 2:00 ... conference call webcast will be available on the company website ... Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call (Date:9/2/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... that protects people from crime and other hostile situations. , \"The Security Services ... Creative Director of World Patent Marketing. \"The industry is growing at a healthy   ...   On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most   ...   Please join the world renowned ... which was established by the Foundation in 2007 with the help of Massachusetts ... more research remains our top priority,” commented Christine Buckley, Executive Director of the   ...   Mobile working is increasingly more important, ... seems that everywhere new mobile apps are being launched, and mobile device usage as ... regular part of their work and personal lives. What's more people are expecting mobile   September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ... [ 0 ] What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention [ 0 ] doTERRA to Host the Largest Single-Company Convention in the State of Utah [ 0 ] September Celebrated as Brain Aneurysm Awareness Month [ 0 ] New Mobility Experience From Winscribe [ 0 ] September is Prostate Cancer Awareness Month ... Inc. (NYSE: FRX ) today announced that ... the Company,s supplemental New Drug Application (sNDA) for Lexapro ... Major Depressive Disorder (MDD) in adolescents, 12 - 17 ... to be approved for the treatment of MDD in ... ... Finding could lead to new treatments for cognitive ... News) -- The human brain functions on \"the ... order and randomness, according to U.K.-based researchers who ... cognitive performance and psychiatric disorders. , The ... ... 20 CANTEL MEDICAL CORP. (NYSE: ... of the Company, to President and Chief Executive Officer. ... of Directors. Since joining Cantel in September 2004, Mr. Krakauer ... 2008 as President. The Board concurrently appointed Seth R. Segel, ... ... the Migraine Research Foundation (MRF) announced a new initiative ... migraine called FOR OUR CHILDREN. The new program ... understanding of migraine and its causes and treatments in ... , Migraine is very common in children - ... ... SEGUNDO, Calif., March 20 A former astronaut and ... a director of business development for Wyle,s Integrated Science ... Parazynski joins Wyle to assist in the company,s continued ... health and performance services to the Federal Government. He ... ... obscure clinical manifestation of severe vomiting sickness due to ... his colleagues at the Creighton University of Omaha, NE, ... of Gastroenterology . , Recent research into the neurobiology ... receptor types including two specific types that mediate neuropsychiatric ... Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents Human Brain Works Between Order and Chaos Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments New initiative to support pediatric migraine research is announced Veteran Astronaut Joins Wyle Business Development Staff in Houston A severe vomiting sickness with chronic cannabis abuse ... the first commercially available real-time detection ... use. , ,The kit can detect ... genotypes of HPV providing the sensitivity ... simplifying the process by using a ... ACMI COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument.... ... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ... An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...", "external_links": [], "published": "2015-09-02T12:45:00.000+03:00", "crawled": "2015-09-02T15:53:18.448+03:00", "highlightTitle": ""}